公司資料
4D Molecular Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- FDMT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
14.54 USD (+19.32%)
收盤價
最後更新: 2026年8月17日
485M USD
市值
股價為何變動
Following the latest company update, “4DMT Announces New Employment Inducement Grants”, FDMT closed up 19.3% at $14.54 on Aug 17, 2026. The move occurred in the trading session associated with this company update.
公司概覽
業務概覽
4D Molecular Therapeutics is a gene-therapy company focused on precision engineered viral vectors and genetic medicine. Its story centers on using vector engineering to improve tissue targeting and therapeutic performance.
所在地與產業分類
4DMT is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and platform biotechnology.
商業模式特徵
The company depends on platform validation, clinical progress, and the ability to convert vector engineering into clinically meaningful products. Investors follow data, safety, and strategic development milestones.
生技產業定位
4D Molecular Therapeutics occupies a premium gene-therapy platform niche within biotech. The stock is catalyst-sensitive because the market is still proving how powerful its vector-engineering approach can be.
未來催化劑
- 4D Molecular Therapeutics's catalysts are 4D-150 and 4D-310, the gene-therapy programs the market will use to judge whether the platform is still gaining traction. Each data update matters because the story is still mostly about platform validation.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。